BeOne Medicines (ONC) PT Raised to $425 at RBC Capital Feb 26, 2026 03:23PM
RBC Capital Reiterates Outperform Rating on BeOne Medicines (ONC) Dec 17, 2025 07:37AM
BeOne Medicines (ONC) PT Raised to $408 at RBC Capital Nov 18, 2025 09:03AM
Biotech stocks: Q3 earnings preview Oct 12, 2025 03:00PM
RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone' Sep 11, 2025 08:18AM


Jul 16, 2025 12:00PM BeOne Medicines (ONC) PT Raised at RBC Capital; 'We See Continued HemeOnc Leadership'
Jun 27, 2025 10:34AM RBC Capital Highlights BeOne Medicines' (ONC) Rich Pipeline
May 13, 2025 06:01AM BeiGene to Present at the RBC Capital Markets Global Healthcare Conference
Apr 7, 2025 06:20AM RBC Capital Starts BeiGene Ltd. (ONC) at Outperform
May 8, 2024 07:00AM Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
May 10, 2022 07:00AM Oncolytics Biotech® to Participate in a Fireside Chat at the 2022 RBC Capital Markets Global Healthcare Conference
May 13, 2021 07:00AM Oncolytics Biotech® to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference
Feb 14, 2018 07:00AM Oncolytics Biotech(R) to Present at the RBC Capital Markets 2018 Healthcare Conference